abstract |
Novel compounds which inhibit LRRK2 kinase activity, processes for their preparation, compositions containing them and diseases characterized by LRRK2 kinase activity, such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS) Their use in treatment or prophylaxis is disclosed. |